Ignite Creation Date:
2025-12-24 @ 3:56 PM
Ignite Modification Date:
2026-02-26 @ 4:14 PM
Study NCT ID:
NCT02621892
Status:
COMPLETED
Last Update Posted:
2020-04-21
First Post:
2015-12-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C
Sponsor:
Ardelyx
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10
Start Date Type:
None
Primary Completion Date:
2017-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04
Completion Date Type:
ACTUAL
First Submit Date:
2015-12-02
First Submit QC Date:
None
Study First Post Date:
2015-12-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-03-30
Results First Submit QC Date:
None
Results First Post Date:
2020-04-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2019-03-15
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2020-04-10
Last Update Post Date:
2020-04-21
Last Update Post Date Type:
ACTUAL